Vermispas 10mg/150mg Tablet
By Vermispas
Rx
10 Tablet in a Strip

Composition
Dicyclomine(10mg) + Ranitidine(150mg)

Manufacturer - Vermilion Healthcare Pvt Ltd
Flat No. B-1, Inderjeet Singh Place, Delhi Gate Main Bazar, Daryaganj New Delhi Central Delhi DL 110002 IN

Expires on or after
October, 2025

liver
Vermispas 10mg/150mg Tablet should be used cautiously in individuals with liver disease. It may be necessary to adjust the dosage of Vermispas 10mg/150mg Tablet in such cases. It is important to consult your doctor for proper guidance on the use of this medication if you have liver issues.

kidney
Vermispas 10mg/150mg Tablet should be used carefully in patients with kidney disease. Dose adjustment may be necessary. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Vermispas 10mg/150mg Tablet.

driving
It is not clear if Vermispas 10mg/150mg Tablet affects driving. Avoid driving if you have symptoms that impact focus and reaction time.

pregnancy
Vermispas 10mg/150mg Tablet is generally safe to use during pregnancy. Animal studies show minimal adverse effects on the baby, but human studies are limited.

breastfeeding
Caution should be taken while breastfeeding if considering Vermispas 10mg/150mg Tablet. Limited information indicates potential harm to the baby as the drug may pass into breastmilk.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹17.2
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024